Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
EPC · NYSE · United States · Perfumes, Cosmetics & Other Toilet Preparations
In shortEDGEWELL PERSONAL CARE Co is profitable, generates cash and carries moderate debt, with revenue stable (−1.3% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 4.3% | 31/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 1.1% | 25/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 1.6% | 8/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 2.6% | 17/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.76× | 80/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.89× | 62/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 6.24× | 0/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.32× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.61 | 39/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 1.9% | 27/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.63× | 100/100 |
| Years with positive free cash flow (last 5) | 3 of 5 | 50/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 3.3% | 99/100 |
| Operating margin volatility | 2.7% | 85/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 0.8% | 21/100 |
|---|---|---|
| EPS growth, 3-year average | -34.1% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 2,087 | 2,172 | 2,252 | 2,254 | 2,224 |
| Cost of revenue | 1,136 | 1,291 | 1,311 | 1,298 | 1,299 |
| Gross profit | 951 | 881 | 941 | 956 | 925 |
| Research & development | 58 | 56 | 59 | 58 | 58 |
| Selling, general & admin | – | – | 410 | 430 | 425 |
| Operating income | 240 | 182 | 227 | 199 | 97 |
| Interest expense | 68 | 71 | 79 | 77 | 73 |
| Pre-tax income | 147 | 124 | 148 | 121 | 24 |
| Income tax | 29 | 25 | 33 | 22 | (1.8) |
| Net income | 118 | 100 | 115 | 99 | 25 |
| Diluted EPS | $2.13 | $1.85 | $2.21 | $1.97 | $0.53 |
| Diluted shares (millions) | 55 | 54 | 52 | 50 | 48 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.61 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026